NCT07324096 2026-03-19
AI-PACED
Mayo Clinic
Phase NA Not yet recruiting
Clinical Trials
49 trialsNCT05846516 2026-03-17
A Study to Test KISIMA-02 Vaccine-based Immunotherapy and Ezabenlimab in People With Pancreatic Cancer
Boehringer Ingelheim
Phase 1 Active not recruiting
NCT07024615 2026-03-13
A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer
Astellas Pharma Inc
Phase 1 Recruiting
NCT07199764 2026-03-06
IGNITE
University of Pennsylvania
Phase 2 Recruiting
NCT06528093 2026-02-03
A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy
Boehringer Ingelheim
Phase 1 Terminated
NCT05634720 2026-01-26
Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer
Duke University
Phase 4 Active not recruiting
NCT06574620 2026-01-16
ACCELERATE
British Columbia Cancer Agency
Phase NA Recruiting
NCT03851237 2025-12-23
CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
Washington University School of Medicine
Phase 1 Completed
NCT05289830 2025-12-10
Escitalopram to Placebo in Patients With Localized Pancreatic Cancer
Case Comprehensive Cancer Center
Phase 2 Terminated
NCT04975217 2025-11-21
Fecal Microbial Transplants for the Treatment of Pancreatic Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT06600906 2025-11-12
Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer
University of California, San Francisco
Recruiting
NCT05209074 2025-09-05
Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma
Case Comprehensive Cancer Center
Phase 1 Active not recruiting
NCT03592888 2025-06-29
DC Vaccine in Pancreatic Cancer
University of Pennsylvania
Phase 1 Completed
NCT03374852 2025-04-29
CPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer
Thomas Jefferson University
Phase 2 Withdrawn
NCT05365893 2025-04-16
PHL Treatment in Pancreatic Cancer
Fox Chase Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT05303090 2025-02-27
Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib for Patients With Advanced Pancreatic Cancer
Fudan University
Phase 1 Completed
NCT05257993 2025-02-19
Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer
Onconic Therapeutics Inc.
Phase 1 Recruiting
NCT05727319 2025-02-07
AIR-PANC
NHS Greater Glasgow and Clyde
Completed
NCT04827953 2024-12-30
NUMANTIA
Nelum Corp
Phase 1/2 Active not recruiting
NCT06079346 2024-08-13
STOP-PC
Mateon Therapeutics
Phase 2/3 Recruiting
NCT05296421 2024-04-10
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
Rutgers, The State University of New Jersey
Phase NA Recruiting
NCT06302881 2024-03-12
Differentiating Tumor-stroma Ratio in Pancreatic Ductal Adenocarcinoma
First Affiliated Hospital of Chongqing Medical University
Unknown
NCT06214533 2024-01-19
CEBOIDS
Sixth Affiliated Hospital, Sun Yat-sen University
Phase NA Unknown
NCT05955157 2024-01-10
Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma
University of Malaya
Phase 2/3 Unknown
NCT06151691 2023-11-30
Assessment of Early Pancreatic Cancer Prognosis by Minimal Residual Disease Using Multi-omics Approach
Fudan University
Unknown
NCT02767700 2023-10-24
PePaCaKa-01
Karolinska University Hospital
Completed
NCT04115527 2023-10-17
Should a Standard Lymphadenectomy Include the No. 16 Lymph Nodes for Patients With Pancreatic Head Adenocarcinoma.
Ruijin Hospital
Phase NA Unknown
NCT05955092 2023-07-21
Exploring the Application of 3D Bioprinting for Personalized Treatment in Pancreatic Ductal Adenocarcinoma
Peking Union Medical College Hospital
Unknown
NCT05611359 2022-11-10
HOPE-1
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Not yet recruiting
NCT03257150 2022-08-11
A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer
University Health Network, Toronto
Phase NA Completed
NCT03012282 2022-07-06
CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer
University of Washington
Phase NA Terminated
NCT02787187 2021-11-23
Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended?
Ruijin Hospital
Phase NA Completed
NCT04310111 2021-08-30
EUS-RFA for Unresectable Pancreatic Cancer
First People's Hospital of Hangzhou
Phase NA Completed
NCT04211948 2021-04-09
Clinical Study Between Robotic and Open Surgery in Patients With Pancreatic Cancer
Ruijin Hospital
Phase NA Unknown
NCT04802993 2021-03-17
Survival Among Patients With Pancreatic Cancer Depending on Surgical Resection Rate
Linkoeping University
Completed
NCT04794140 2021-03-11
A Clinical Study to Evaluated Which Number of Passes of EUS-FNB is Better for Culturing Primary Cells of PDAC
The Third Xiangya Hospital of Central South University
Phase NA Unknown
NCT03138213 2020-10-08
Comparing Total Laparoscopic Versus Open Pancreaticoduodenectomy
Tongji Hospital
Phase NA Unknown
NCT02790944 2020-08-25
Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer
Ambry Genetics
Completed
NCT04134468 2020-01-31
MRI Effects of Pegvorhyaluronidase Alfa (PEGPH20) in Pancreatic Ductal Adenocarcinoma
Abramson Cancer Center at Penn Medicine
Phase 2 Withdrawn
NCT04164992 2019-11-18
Endoscopic Ultrasound Radiofrequency Ablation (EUS-RFA) of Not-resectable Pancreatic Cancer
Campus Bio-Medico University
Phase NA Unknown
NCT02926183 2019-10-03
Study of NAC of GA Therapy for Patients With BRPC
Wakayama Medical University
Phase 2 Unknown
NCT03973736 2019-06-04
RevRadPAC
Azienda USL Reggio Emilia - IRCCS
Completed
NCT02440958 2019-02-18
Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial
Yonsei University
Phase 2 Completed
NCT03687853 2018-09-27
Application of Intrahepatic Arterial Infusion Chemotherapy for Patients With High Risk of Liver Metastases After Pancreatic Cancer Surgery
Peking University Third Hospital
Phase NA Unknown
NCT03317886 2017-10-24
Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer
Wakayama Medical University
Phase 3 Unknown
NCT03316326 2017-10-20
S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer
National Taiwan University Hospital
Phase 2 Unknown
NCT01911416 2016-06-09
A Biomarker Study to Identify Predictive Signatures of Response to LDE225 (Hedgehog Inhibitor) In Patients With Resectable Pancreatic Cancer
University of Utah
Phase NA Withdrawn
NCT01962909 2016-03-18
Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer
University of Virginia
Phase EARLY_PHASE1 Terminated
NCT01879878 2015-05-28
POUDER
Heidelberg University
Phase NA Unknown